RTA 408 Capsules in Patients With Melanoma - REVEAL

Clinical trial NCT02259231 · COMPLETED

Trial details

NCT number: NCT02259231
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Unresectable (Stage III) Melanoma Metastatic (Stage IV) Melanoma

Start date: 2014-10-31
Primary completion: 2018-05-09
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.